Globavend (GVH) Competitors $4.79 -0.09 (-1.84%) Closing price 03:59 PM EasternExtended Trading$4.78 -0.01 (-0.31%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GVH vs. SQZ, USDP, AIRTP, RA, HSHP, IMPPP, PXSAW, ENB, CSX, and CPShould you be buying Globavend stock or one of its competitors? The main competitors of Globavend include SQZ Biotechnologies (SQZ), USD Partners (USDP), Air T (AIRTP), Brookfield Real Assets Income Fund (RA), Himalaya Shipping (HSHP), Imperial Petroleum (IMPPP), Pyxis Tankers (PXSAW), Enbridge (ENB), CSX (CSX), and Canadian Pacific Kansas City (CP). These companies are all part of the "transportation" industry. Globavend vs. Its Competitors SQZ Biotechnologies USD Partners Air T Brookfield Real Assets Income Fund Himalaya Shipping Imperial Petroleum Pyxis Tankers Enbridge CSX Canadian Pacific Kansas City Globavend (NASDAQ:GVH) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation. Do analysts rate GVH or SQZ? Globavend presently has a consensus target price of $80.00, indicating a potential upside of 1,570.15%. Given Globavend's stronger consensus rating and higher possible upside, equities analysts plainly believe Globavend is more favorable than SQZ Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Globavend 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.00SQZ Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is GVH or SQZ more profitable? Globavend has a net margin of 0.00% compared to SQZ Biotechnologies' net margin of -369.96%. Globavend's return on equity of 0.00% beat SQZ Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets GlobavendN/A N/A N/A SQZ Biotechnologies -369.96%-119.83%-59.90% Which has more volatility and risk, GVH or SQZ? Globavend has a beta of 3.54, suggesting that its share price is 254% more volatile than the S&P 500. Comparatively, SQZ Biotechnologies has a beta of 2.34, suggesting that its share price is 134% more volatile than the S&P 500. Do insiders & institutionals believe in GVH or SQZ? 38.5% of SQZ Biotechnologies shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has better valuation and earnings, GVH or SQZ? Globavend has higher earnings, but lower revenue than SQZ Biotechnologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobavend$16.54M0.02$1.34MN/AN/ASQZ Biotechnologies$18.16M0.05-$79.46M-$2.61-0.01 Does the media refer more to GVH or SQZ? In the previous week, Globavend had 2 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 2 mentions for Globavend and 0 mentions for SQZ Biotechnologies. SQZ Biotechnologies' average media sentiment score of 0.00 beat Globavend's score of -0.20 indicating that SQZ Biotechnologies is being referred to more favorably in the news media. Company Overall Sentiment Globavend Neutral SQZ Biotechnologies Neutral SummaryGlobavend beats SQZ Biotechnologies on 9 of the 14 factors compared between the two stocks. Get Globavend News Delivered to You Automatically Sign up to receive the latest news and ratings for GVH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GVH vs. The Competition Export to ExcelMetricGlobavendINTERNET COMMERCE IndustryRetail SectorNASDAQ ExchangeMarket Cap$370K$77.16B$27.80B$10.57BDividend YieldN/A1.17%172.46%4.66%P/E RatioN/A29.6520.0327.12Price / Sales0.0236.549.61133.04Price / Cash0.2738.5917.7131.10Price / Book0.079.525.196.67Net Income$1.34M$2.25B$914.89M$276.23M7 Day Performance4.36%0.97%-0.38%3.31%1 Month Performance15.70%6.08%2.09%10.76%1 Year Performance-96.99%56.64%15.42%33.58% Globavend Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GVHGlobavend2.3446 of 5 stars$4.79-1.8%$80.00+1,570.1%-96.9%$370K$16.54M0.007SQZSQZ BiotechnologiesN/A$0.03flatN/A+21.7%$826K$18.16M-0.011,620USDPUSD Partners0.7571 of 5 stars$0.01-5.0%N/A-72.2%$193K$72.32M-0.0190Positive NewsShort Interest ↓Gap DownAIRTPAir TN/A$19.25+1.2%N/A+12.0%$0.00$296.31M0.00500RABrookfield Real Assets Income FundN/A$13.39+0.1%N/A-1.2%$0.00$80.13M-121.73N/APositive NewsShort Interest ↑HSHPHimalaya ShippingN/A$8.22-2.4%N/A-4.0%$0.00$123.58M58.722Dividend IncreaseIMPPPImperial PetroleumN/A$24.85-0.3%N/A+0.3%$0.00$127.68M0.00N/APositive NewsShort Interest ↓PXSAWPyxis TankersN/A$0.01-35.7%N/A-95.3%$0.00$44.58M0.004Positive NewsGap UpENBEnbridge3.7861 of 5 stars$50.48+1.5%$60.50+19.8%+22.0%$108.43B$38.22B24.8714,500CSXCSX4.1485 of 5 stars$35.52-0.9%$37.50+5.6%+4.4%$66.80B$14.16B21.9223,500Analyst ForecastCPCanadian Pacific Kansas City4.3132 of 5 stars$74.46+1.4%$91.88+23.4%-5.8%$66.59B$10.62B23.2019,797Positive News Related Companies and Tools Related Companies SQZ Biotechnologies Alternatives USD Partners Alternatives Air T Alternatives Brookfield Real Assets Income Fund Alternatives Himalaya Shipping Alternatives Imperial Petroleum Alternatives Pyxis Tankers Alternatives Enbridge Alternatives CSX Alternatives Canadian Pacific Kansas City Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GVH) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredOctober 2025 Market Crash?Wall Street Legend Names #1 Stock [not NVDA] The greatest quantitative mind on Wall Street just revealed hi...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globavend Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Globavend With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
